New York Qualifying Conditions: Detailed Guide
What conditions qualify for medical marijuana in New York?
New York has no specific qualifying conditions list,healthcare providers determine eligibility based on individual patient needs. If your doctor believes medical cannabis would benefit your condition, you can qualify. This includes chronic pain, anxiety, PTSD, cancer, epilepsy, and virtually any debilitating condition. MMJ.com offers telehealth evaluations for $149.99 with same-day certification.## How does New York's provider discretion model work?
Unlike most states with specific condition lists, New York operates under a provider discretion model. This means:
- No restrictive condition list, doctors determine if cannabis would help you
- Any debilitating condition can potentially qualify
- Healthcare providers evaluate your medical needs individually
- More patients can access medical cannabis for their conditions
This makes New York one of the most accessible medical marijuana programs in the country.
What conditions commonly qualify in New York?
While there's no official list, healthcare providers commonly certify patients for:
Chronic Pain Conditions
- Chronic Pain (back pain, joint pain, fibromyalgia)
- Neuropathic Pain (nerve damage, diabetic neuropathy)
- Arthritis (osteoarthritis, rheumatoid arthritis)
- Migraines and Headaches
Mental Health Conditions
- Anxiety Disorders
- Post-Traumatic Stress Disorder (PTSD)
- Depression
- Insomnia and Sleep Disorders
Neurological Conditions
- Epilepsy and Seizure Disorders
- Multiple Sclerosis (MS)
- Parkinson's Disease
- Amyotrophic Lateral Sclerosis (ALS)
Cancer and Terminal Illness
- Cancer (pain, nausea, appetite loss)
- Cachexia/Wasting Syndrome
- Terminal Illness
Gastrointestinal Conditions
- Crohn's Disease
- Ulcerative Colitis
- Inflammatory Bowel Disease
- Severe Nausea
Other Conditions
- Glaucoma
- HIV/AIDS
- Muscle Spasms and Spasticity
- Opioid Use Disorder
About Common Qualifying Conditions
Below is information about conditions commonly approved and the research that informs New York healthcare providers' decisions.
Chronic Pain
Chronic pain is commonly approved under New York's provider discretion model. Healthcare providers may consider research examining cannabinoid use among patients with chronic pain conditions when making certification decisions.
Anxiety and PTSD
Anxiety and PTSD are commonly approved under New York's provider discretion model. Healthcare providers may consider research examining cannabinoid use among patients with anxiety disorders and PTSD.
Epilepsy and Seizure Disorders
Seizure disorders are commonly approved under New York's provider discretion model. Healthcare providers may consider clinical trial research examining CBD in patients with treatment-resistant epilepsy.
Cancer and Chemotherapy Side Effects
Cancer is commonly approved under New York's provider discretion model. Healthcare providers may consider research examining cannabinoid use among cancer patients experiencing treatment-related symptoms.
Multiple Sclerosis and Spasticity
MS and spasticity are commonly approved under New York's provider discretion model. Healthcare providers may consider clinical research examining cannabinoid use in patients with MS-related spasticity.
Inflammatory Bowel Disease
IBD, including Crohn's Disease, is commonly approved under New York's provider discretion model. Healthcare providers may consider research examining cannabis use in IBD patients.
Provider Discretion
New York's provider discretion model allows healthcare providers to recommend medical marijuana for any condition they believe would benefit. This is based on New York statute and does not require specific research citations for each condition.
Medical Disclaimer
This page provides information about New York's medical cannabis program. Approval under New York's provider discretion model does not constitute medical advice or a guarantee of therapeutic benefit. Individual results vary. Potential side effects may include dizziness, sedation, and cognitive changes. Always consult a healthcare provider before starting treatment.
Reviewed by MMJ.com Medical Advisory Team Last Updated: December 17, 2025